Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

COVID-19 pandemic could be result of incremental bat virus evolution

By Brian Buntz | March 15, 2021

Horseshoe bat

Smithers’ horseshoe bat is a relative of the bat that likely gave rise to the pandemic. Image courtesy of Wikipedia.

When a virus jumps from one host to another, it usually acquires new capabilities to target cells beforehand.

But the SARS-CoV-2 virus seems to have needed little prior adaptation before causing a pandemic, according to a recent study in PLOS Biology.

The genus betacoronavirus to which SARS-CoV-2 belongs is notorious for its threat of jumping from animals to humans. Indeed, the genus is responsible for several outbreaks in the past two decades, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and, more recently, COVID-19.

The PLOS Biology study concluded that the nearest viral ancestor to SARS-CoV-2 is RmYN02, which evolved in bats. The ancestor virus of SARS-CoV-2 was likely a “relatively generalist virus” that was capable of efficient human-to-human transmission. It is still possible that an intermediate species spread SARS-CoV-2 to humans.

The main difference between the virus behind the earlier SARS outbreak and SARS-CoV-2 is the latter’s increased ability to cleave to angiotensin-converting enzyme 2 (ACE-2), allowing it to infect cells in humans’ upper respiratory tract, albeit with lower disease severity. Paradoxically, however, this capability leads to a more significant disease burden, given the greater case counts linked to SARS-CoV-2 than SARS-CoV, which is now also called SARS-CoV-1.

Bat evolution

Schematic of our proposed evolutionary history of the nCoV clade and putative events leading to the emergence of SARS-CoV-2.
Image courtesy of:
MacLean OA, et al. (2021), Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen. PLoS Biol 19(3): e3001115. CC-BY

Despite the attention recently given to SARS-CoV-2 variants, the virus has not meaningfully evolved after it began infecting humans roughly a year ago based on the hundreds of thousands of sequenced virus genomes.

“This does not mean no changes have occurred, mutations of no evolutionary significance accumulate and ‘surf’ along the millions of transmission events, like they do in all viruses,” said Dr. Oscar MacLean, who coauthored the PLOS Biology study. While mutations affecting the virus spike improve transmissibility, “‘neutral’ evolutionary processes have dominated,” according to MacLean.


Filed Under: Infectious Disease
Tagged With: bats, coronavirus, covid-19, infectious diseases
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

covid-19 vaccine
FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
Pfizer-BioNTech
Pfizer and BioNTech forge new COVID-19 vaccine deal with U.S. government
Icosavax
Icosavax shares positive early results for VLP vaccine candidate against RSV
FDA logo
VRBPAC backs adding omicron-component to COVID-19 boosters

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50